Label-free electrochemical biosensor for direct detection of Oncostatin M (OSM) inflammatory bowel diseases (IBD) biomarker in human serum
Abstract
No abstract availableKeywords
Funding Information
- European Commission
This publication has 32 references indexed in Scilit:
- Atomic Force Microscopy of DNA and DNA-Protein Interactions2022
- Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassayClinical Biochemistry, 2022
- Direct imaging of antigen–antibody binding by atomic force microscopyApplied Nanoscience, 2020
- Probing antibody surface density and analyte antigen incubation time as dominant parameters influencing the antibody-antigen recognition events of a non-faradaic and diffusion-restricted electrochemical immunosensorAnalytical and Bioanalytical Chemistry, 2020
- Surface plasmon resonance imaging coupled to on-chip mass spectrometry: a new tool to probe protein-GAG interactionsAnalytical and Bioanalytical Chemistry, 2019
- Advances in electrochemical immunosensors2019
- Label-free cytokine micro- and nano-biosensing towards personalized medicine of systemic inflammatory disordersAdvanced Drug Delivery Reviews, 2015
- A review on novel developments and applications of immunosensors in food analysisAnalytica Chimica Acta, 2007
- Label‐Free Impedance Biosensors: Opportunities and ChallengesElectroanalysis, 2007
- Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's diseaseJournal of Clinical Immunology, 1996